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Hamanaka et al. show that loss of
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promotes cutaneous vasodilation and
blood flow during hypoxia and
potentiates the hypoxic response in the
internal organs, mice with loss of TFAM in
the epidermis are unable to induce renal
erythropoietin expression in response to
hypoxia.
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Hypoxia-inducible factors (HIFs) are crucial for
cellular and organismal adaptation to hypoxia. The
mitochondrial respiratory chain is the largest con-
sumer of oxygen in most mammalian cells; however,
it is unknown whether the respiratory chain is
necessary for in vivo activation of HIFs and organ-
ismal adaptation to hypoxia. HIF-1 activation in the
epidermis has been shown to be a key regulator
of the organismal response to hypoxic conditions,
including renal production of erythropoietin (Epo).
Therefore, we conditionally deleted expression of
TFAM in mouse epidermal keratinocytes. TFAM is
required for maintenance of the mitochondrial
genome, and TFAM-null cells are respiratory defi-
cient. TFAM loss in epidermal keratinocytes reduced
epidermal levels of HIF-1a protein and diminished
the hypoxic induction of HIF-dependent transcrip-
tion in epidermis. Furthermore, epidermal TFAMdefi-
ciency impaired hypoxic induction of renal Epo
expression. Our results demonstrate that the mito-
chondrial respiratory chain is essential for in vivo
HIF activation and organismal adaptation to hypoxia.
INTRODUCTION
The importance of oxygen homeostasis for the survival of eu-
karyotes has necessitated the evolution of multiple mechanisms
by which organisms maintain their oxygen supply. The cellular
response to hypoxia is governed largely by a family of transcrip-
tion factors termed hypoxia-inducible factors (HIFs), which
promote the activation of genes involved in glycolysis, angiogen-
esis, cell-cycle regulation, and survival (Semenza, 2012). Under
normoxic conditions, proline residues within the oxygen-depen-
dent degradation domain of HIF-a subunits (HIF-1a, HIF-2a, and
HIF-3a) are hydroxylated by a family of 2-oxoglutarate-depen-
dent dioxygenases termed prolyl hydroxylases 1, 2, and 3
(PHD1–3) (Kaelin and Ratcliffe, 2008). This proline-directed hy-
droxylation targets HIF-a subunits for recognition by a ubiquitin
ligase containing the von Hippel-Lindau tumor suppressor pro-
tein (VHL). The activity of PHD proteins is inhibited during
hypoxia, stabilizing HIF-a subunits, leading to their dimerizationThis is an open access article under the CC BY-Nwith a common b-subunit (HIF-1b) and transactivation of HIF
target genes.
Mitochondrial metabolism has been implicated in regulating
the hydroxylation reaction carried out by PHDs. Mitochondrial
generation of tricarboxylic acid (TCA) cycle intermediates, con-
sumption of oxygen, and production of reactive oxygen species
(ROS) have been shown to inhibit the hydroxylation of HIFs, re-
sulting in activation of HIF target genes (Bell et al., 2007; Brunelle
et al., 2005; Guzy et al., 2005; Hagen et al., 2003; Isaacs et al.,
2005; Mansfield et al., 2005; Pan et al., 2007; Selak et al.,
2005; Sullivan et al., 2013). Despite evidence for the role of mito-
chondrial metabolism in regulating the cellular response to hyp-
oxia, it remains to be demonstrated whether this phenomenon,
heretofore observed only in cell culture, plays a physiological
role in the mammalian systemic response to hypoxia in vivo.
Epidermal keratinocytes have been shown to play a critical
role in regulating the systemic response to hypoxia (Boutin
et al., 2008). The epidermis, which obtains oxygen directly
from the atmosphere, responds to reductions in atmospheric
oxygen by inducing vasodilation in the underlying dermis in a
HIF- and nitric-oxide-dependent manner (Boutin et al., 2008;
Minson, 2003; St€ucker et al., 2002). This hypoxic vasodilation
in the skin results in reduced blood flow to the internal organs,
increasing internal hypoxia and promoting renal production of
erythropoietin (Epo), a glycoprotein hormone that promotes pro-
liferation and differentiation of erythroid progenitor cells into red
blood cells, increasing the oxygen carrying capacity of the blood
(Boutin et al., 2008; Bunn et al., 1998).
We recently reported on mice that lack expression of tran-
scription factor A, mitochondrial (TFAM) in epidermal keratino-
cytes (Hamanaka et al., 2013). TFAM is required for transcription
and replication of the mitochondrial genome, and cells lacking
TFAM are respiratory deficient (Larsson et al., 1998). Loss of
TFAM in epidermal keratinocytes resulted in epidermal barrier
function defects and lethality 2 weeks after birth. The epidermal
defect was due to a decrease in the production of mitochondrial
ROS, which is necessary for Notch-dependent epidermal differ-
entiation (Hamanaka et al., 2013). Here, we show that epidermal
keratinocytes derived from these TFAM epidermal knockout
(TFAM EpiKO) mice display impaired HIF activation upon expo-
sure to hypoxia. Furthermore, neonatal mice displayed dimin-
ished HIF-1a protein and target gene induction in their epidermis
after exposure to hypoxia. This resulted in an impaired hypoxic
induction of Epo expression in the kidneys of these mice. Renal
Epo expression could be induced in TFAM EpiKO mice byCell Reports 15, 451–459, April 19, 2016 ª2016 The Authors 451
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Mitochondrial Generation of ROS Is Required for Hypoxic Induction of HIF-1a Protein and Target Gene Expression in Mouse
Epidermal Keratinocytes
(A) Representative western blot analysis of HIF-1a and TFAM protein levels in primary mouse keratinocytes isolated from wild-type and TFAM EpiKO mice. Cells
were exposed to normoxia (21% O2) or hypoxia (1.5% O2) for 4 hr.
(B) Real-time PCR analysis of HIF-1a and TFAM mRNA expression in primary mouse keratinocytes isolated from wild-type and TFAM EpiKO mice.
(C) Real-time PCR analysis of PGK1, CAIX, Pai1, VEGF, and BNIP3 mRNA expression in primary mouse keratinocytes isolated from wild-type and TFAM EpiKO
mice. Cells were exposed to normoxia or hypoxia for 4 hr.
(D) Representative western blot analysis of HIF-1a protein levels in primary wild-type mouse keratinocytes after exposure to normoxia or hypoxia for 4 hr. Cells
were treated with mitochondria-targeted vitamin E (MVE; 1uM) or the control compound methyl-triphenylphosphonium (TPP; mitochondria-targeting moiety
lacking antioxidant activity).
(legend continued on next page)
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pharmacologic promotion of cutaneous vasodilation or by co-
deletion of VHL, demonstrating conclusively the link between
mitochondria and the HIF degradation machinery in vivo.
RESULTS
TFAM EpiKO mice were generated by crossing mice bearing
floxed alleles of TFAM tomice that expressCre recombinase un-
der the control of the keratin-14 promoter (Dassule et al., 2000).
We have previously demonstrated that primary epidermal kera-
tinocytes isolated from TFAM EpiKO mice do not consume oxy-
gen or produce mitochondrial ROS (mROS) (Hamanaka et al.,
2013). Consistent with their inability to initiate mitochondria-
dependent signaling events, primary epidermal keratinocytes
isolated from TFAMEpiKOmice displayed an impaired induction
of HIF-1aprotein after exposure to hypoxia (1.5%O2) (Figure 1A).
Hypoxic accumulation of HIF-2a was similarly inhibited in TFAM
EpiKO keratinocytes (Figure S1A). The failure of TFAM EpiKO
keratinocytes to induce HIF-1a was not the result of decreased
HIF-1amRNA expression (Figure 1B) but was due to the inability
of these cells to stabilize HIF-1a protein upon exposure to
hypoxia. This resulted in impaired transcriptional induction of
HIF-1a target genes that regulate metabolism (phosphoglyc-
erate kinase-1; [PGK1] and BCL2/adenovirus E1B 19-kDa inter-
acting protein 3 [BNIP3]), pH balance (carbonic anhydrase 9
[CAIX]), and blood flow (vascular endothelial growth factor
[VEGF] and plasminogen activator inhibitor 1 [Pai1]) (Figure 1C).
The inability of TFAM-null cells to respond to hypoxia was not
due to bioenergetic defects; keratinocytes treated with deferox-
amine (DFO), an iron chelator that stabilizes HIF-1a protein under
normoxic conditions (Wang and Semenza, 1993), resulted in
HIF-1a protein accumulation as well as HIF-1a target gene
expression in both wild-type and TFAM EpiKO cells (Figures
S1B and S1C).
We have previously demonstrated that mROS are critical
signaling regulators of hypoxic HIF activation (Bell et al.,
2007; Brunelle et al., 2005; Chandel et al., 2000). Consistent
with this, the effects of TFAM knockout on HIF-1a stabilization
were mimicked by the treatment of wild-type keratinocytes
with antioxidants such as N-acetylcysteine and mitochondria-
targeted vitamin E (Figures 1D and S1D). To determine if eleva-
tion of cellular ROS levels could rescue HIF-1a stabilization in
the absence of mROS production, we treated TFAM EpiKO
cells with the redox cycling agent 2,3-dimethoxy-4-naphtho-
quinone (DMNQ). DNMQ has previously been demonstrated
to increase cellular ROS levels, leading to HIF-1a stabilization
in transformed cells (Ko¨hl et al., 2006). Treatment with DMNQ
induced HIF-1a protein accumulation in TFAM EpiKO keratino-
cytes (Figure 1E). Mitochondrial respiratory complex III has
been shown to be the major site of mROS production neces-
sary for HIF-1a protein stabilization during hypoxia (Bell
et al., 2007; Orr et al., 2015). Thus, acute knockdown of the
complex III subunit Reiske iron sulfur protein (RISP) diminished(E) Representative western blot analysis of HIF-1a protein levels in TFAM Ep
2,3-dimethoxy-4-naphthoquinone (DMNQ; 100uM) for 4 hr.
Charts represent means ± SEM. n = 4 independent keratinocyte preparations per
determined by (B) Student’s t test or (C) one-way ANOVA using Bonferroni’s posHIF-1a protein stabilization to a similar extent as TFAM
knockout (Figure S1E). Collectively, these results demonstrate
that TFAM EpiKO keratinocytes exhibit diminished HIF-1a pro-
tein stabilization after exposure to hypoxia due to their inability
to produce mROS.
Elimination of TFAM expression in the epidermal keratinocytes
ofmice leads to premature follicular catagen and development of
a hyperplastic interfollicular epidermis (Hamanaka et al., 2013;
Figure S2A). TFAM EpiKO mice develop an epidermal barrier
defect at postnatal day 14.5 (P14.5) and die soon thereafter (Ha-
manaka et al., 2013), therefore all in vivo experiments on these
mice were conducted at day P9.5. Consistent with previous
reports (Bedogni et al., 2005; Boutin et al., 2008; Wong et al.,
2015), the epidermis of wild-type mice displayed constitutive
expression of HIF-1a protein, even under normoxic conditions
(Figure 2A). Reduced levels of HIF-1a protein were observed
in the epidermal cells of TFAM EpiKO mice when compared
to wild-type mice. As observed in cultured keratinocytes, the
diminished HIF-1a protein level was not due to a decrease in
HIF-1a mRNA expression in the TFAM EpiKO epidermis as
epidermal HIF-1a mRNA levels in wild-type and TFAM EpiKO
mice were similar (Figure 2B).
Despite the constitutive levels of HIF-1a protein observed in
normoxic wild-type mice, exposure of wild-type mice to hypoxia
(9%O2) for 16 hr led to an additional accumulation of HIF-1a pro-
tein in epidermal cells as well as increased expression of HIF-1a
target genes (Figures 2C–2E). Exposure of TFAM EpiKO mice to
hypoxia resulted in an attenuated induction of HIF-1a protein
and no increase in the expression of HIF-1a target genes (Fig-
ures 2C–2E).
Activation of the HIF response in epidermal keratinocytes
promotes the systemic response to hypoxia by promoting nitric
oxide (NO)-dependent vasodilation in the underlying dermis,
shunting blood away from the internal organs and causing
them to encounter greater levels of hypoxia than they would
in the absence of the epidermal response (Boutin et al.,
2008). Kidneys respond to this increased level of hypoxia by
producing the glycoprotein hormone erythropoietin (Epo), a
HIF-2a target gene (Gruber et al., 2007; Rankin et al., 2007).
After exposure to hypoxia for 16 hr, expression of Epo mRNA
was highly induced in the kidneys of wild-type mice, an effect
that was inhibited in TFAM EpiKO mice (Figure 3A). This led
to reduced levels of Epo protein in the serum of TFAM EpiKO
mice after exposure to hypoxia (Figure 3B). Hypoxic induction
of HIF-1a target genes such as PGK1, BNIP3, Pai1, CTGF (con-
nective tissue growth factor), and Glut1 (glucose transporter 1)
was also inhibited in the kidneys of TFAM EpiKO mice (Fig-
ure 3E). As in the epidermis, the renal mRNA expression of
both HIF-1a and HIF-2a was similar between wild-type and
TFAM EpiKO mice (Figure 3C). Furthermore, the levels of renal
TFAM expression were not affected in TFAM EpiKO mice, indi-
cating the specificity of the keratin 14-driven Cre for epidermal
cells (Figure 3D).iKO primary mouse keratinocytes after exposure to normoxia, hypoxia, or
genotype. mRNA expression was normalized to RPL19 levels. Significance was
t test.
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Figure 2. Hypoxic Induction of HIF-1a Pro-
tein and Target Gene Expression Is Inhibited
in the Epidermis of TFAM EpiKO Mice
(A) Representative immunohistochemical analysis
of HIF-1a protein expression in the epidermis of
wild-type and TFAM EpiKO mice.
(B) Real-time PCR analysis of HIF-1a and TFAM
mRNA expression in the epidermis of wild-type
and TFAM EpiKO mice.
(C) Representative western blot analysis of HIF-1a
and TFAM protein levels in epidermal lysates
prepared from wild-type and TFAM EpiKO mice.
Mice were exposed to normoxia (21% O2) or
hypoxia (9% O2) for 16 hr.
(D) Densitometric quantification of (C). HIF-1a
protein levels were normalized to b-actin levels.
(E) Real-time PCR analysis of PGK1, CAIX, Pai1,
VEGF, and BNIP3 mRNA expression in epidermal
lysates prepared from wild-type and TFAM EpiKO
mice. Mice were exposed to normoxia or hypoxia
for 16 hr.
Charts represent means ± SEM. n = 5 mice per
genotype per condition. mRNA expression was
normalized to RPL19 levels. Significance was
determined by one way ANOVA using Bonferroni’s
post test.Pharmacologic induction of cutaneous NO is sufficient to
induce renal Epo expression in the absence of hypoxic stimuli
(Boutin et al., 2008). We found that the dermal vascular density
of TFAM EpiKO mice was similar to that of wild-type mice
when assessed using the endothelial marker CD31 (Figure S2B).
Thus, we sought to determine whether TFAM EpiKO mice
remained sensitive to cutaneous application of mustard seed
oil (allyl isothiocyanate), which promotes NO synthesis. Indeed,
application of mustard seed oil to the skin of wild-type or
TFAM EpiKO mice induced renal Epo mRNA expression to a
similar extent (Figure 3F). These results suggest that the
impaired hypoxic Epo induction observed in TFAM EpiKO mice
is the result of an oxygen sensing defect within the epidermis.
Since mitochondrial metabolism and mROS production regu-
late HIF activity upstream of recognition by the VHL-containing454 Cell Reports 15, 451–459, April 19, 2016ubiquitin ligase, we sought to determine
if epidermal deletion of VHL could rescue
HIF-1a activity in the epidermal keratino-
cytes of TFAM EpiKO mice. To do this,
we generated a mouse expressing floxed
alleles of both TFAM and VHL and
knocked out expression of both genes in
the epidermis of mice using the keratin-
14 Cre allele. Mice lacking expression of
VHL in the epidermis were notable at birth
as they were red in color due to increased
cutaneous blood flow (Figures 4A and
4B). Both VHL EpiKO and TFAM+VHL
EpiKO mice exhibited perinatal mortality,
dying by day P5.5. At day P3.5, however,
increased levels of HIF target genemRNA
were detected in epidermal lysates fromboth VHL EpiKO and TFAM+VHL EpiKO mice (Figure 4C).
Furthermore, epidermal deletion of VHL elevated renal Epo
expression to a similar extent in mice either heterozygous or
homozygous for the TFAM floxed allele (Figure 4D).
DISCUSSION
At the cellular level, HIFs are crucial for metabolic adaptation to
hypoxia (Semenza, 2010). Mitochondria are the primary cellular
consumers of oxygen, and mitochondrial generation of TCA cy-
cle intermediates, oxygen consumption, and production of ROS
have all been demonstrated to regulate the activity of HIF prolyl
hydroxylases (Bell et al., 2007; Brunelle et al., 2005; Guzy et al.,
2005; Hagen et al., 2003; Isaacs et al., 2005; Mansfield et al.,
2005; Pan et al., 2007; Selak et al., 2005; Sullivan et al., 2013).
Figure 3. Hypoxic Induction of HIF-1a Target Genes and Erythropoietin Is Inhibited in the Kidneys of TFAM EpiKO Mice
(A) Real-time PCR analysis of Epo mRNA expression in renal lysates prepared fromwild-type and TFAM EpiKOmice. Mice were exposed to normoxia or hypoxia
for 16 hr.
(B) Epo protein concentrations in the serum of wild-type and TFAM EpiKO mice as determined by ELISA.
(C and D) Real-time PCR analysis of (C) HIF-1a, HIF-2a, or (D) TFAM mRNA expression in the kidneys of wild-type and TFAM EpiKO mice.
(legend continued on next page)
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Despite accumulating evidence for mitochondrial regulation of
HIF, this requirement had yet to be demonstrated in vivo. In
this report, we demonstrate that the mitochondrial respiratory
chain is an essential regulator of HIF-1 in vivo.
Our results demonstrate that although cells that lack TFAM
expression are unable to conduct mitochondrial oxidative phos-
phorylation, they are energetically capable of inducing HIF-1a
protein stabilization when PHD proteins or VHL are inhibited; it
is the signaling upstream of the PHD proteins that is inhibited
in the absence of TFAM. Thus, inhibition of PHD proteins with
DFO or pharmacological elevation of cellular ROS levels with
DMNQ was sufficient to induce HIF activity in TFAM EpiKO ker-
atinocytes. In addition, our results support a role for mROS as
crucial regulators of hypoxia signaling, as treatment of wild-
type keratinocytes with N-acetylcysteine or mitochondria-tar-
geted vitamin E inhibited HIF accumulation to a similar extent
as TFAM deletion in vitro. To conclusively demonstrate the role
that mROS generation plays in promoting HIF activity in vivo, it
will be critical to develop genetic tools that impair mROSproduc-
tion without simultaneously affecting oxidative phosphorylation.
Our results support previous findings that demonstrate that
HIF activation in the epidermis promotes Epo production in the
kidney. While it was previously demonstrated that deletion of
epidermal HIF-1a expression impaired the renal response to
hypoxia (Boutin et al., 2008), we now demonstrate that deletion
of TFAM in epidermal keratinocytes recapitulates the effect
of epidermal HIF-1a deletion. Although deletion of TFAM in
epidermal cells inhibited hypoxic sensation and renal induction
of Epo, these mice remained sensitive to the effects of cuta-
neous NO elevation or to co-deletion of epidermal VHL, support-
ing a crucial role for mitochondrial signaling upstream of VHL.
These results demonstrate that mitochondria act as oxygen sen-
sors in vivo, promoting HIF activation and adaptation to hypoxic
conditions. While it is unclear why deletion of VHL in the
epidermis resulted in early mortality, it was recently shown that
in addition to regulating hypoxic adaptation, epidermal HIF levels
regulate systemic arterial pressure and thermoregulation in mice
(Cowburn et al., 2013). Thus, our results add to the increasing ev-
idence for the importance of oxygen sensing and HIF activation
within the epidermis for organismal homeostasis.
The importance of mitochondria as regulators of HIF signaling
is highlighted by the fact that in a chemical screen of over
600,000 compounds, the 200most effective inhibitors of hypoxic
HIF activation were determined to be mitochondrial inhibitors
(Lin et al., 2008). While the toxicities of mitochondrial inhibitors
such as rotenone and cyanide are well known, metformin, an
inhibitor of complex I of the respiratory chain, is well tolerated
in patients receiving it as a diabetes treatment. We recently
demonstrated that metformin inhibits mROS generation and
hypoxic HIF activation in cancer cells (Wheaton et al., 2014).
Recently, Brand and colleagues identified multiple classes of(E) Real-time PCR analysis of CTGF, BNIP3, GLUT1, PAI1 and PGK1 mRNA expr
(21% O2) or hypoxia (9% O2) for 16 hr.
(F) Real-time PCR analysis of Epo mRNA expression in the kidneys of wild-type
seed oil (allyl isothiocyanate) or EtOH as vehicle control.
Charts represent means ± SEM. mRNA expression was normalized to RPL19 le
determined by one-way ANOVA using Bonferroni’s post test.
456 Cell Reports 15, 451–459, April 19, 2016compounds that inhibit mROS production from respiratory com-
plex III without affecting mitochondrial energy metabolism (Orr
et al., 2015). Although the in vivo efficacy of these compounds
remains to be determined, these selective suppressors of com-
plex III superoxide generation inhibited hypoxic induction of
HIF-1a in cultured cells. Since hypoxia and aberrant HIF levels
are associated with human pathologies such as pulmonary hy-
pertension and cancer, it is of great importance to continue
studying the mechanisms of mitochondrial HIF regulation.
EXPERIMENTAL PROCEDURES
Mice and Keratinocyte Culture
All animal experiments were approved by Northwestern University’s Institu-
tional Animal Care and Use Committee.
TFAM floxed mice (TFAMfl/fl) mice were generated as described previously
(Larsson et al., 1998) and were crossed with KRT14-Cre mice (Jackson Labora-
tory, stock no. 004782) (Dassule et al., 2000). Heterozygous TFAMfl/+;K14Cre+/
mice were mated back to TFAMfl/fl mice to obtain control (K14Cre/) and
TFAM EpiKO mice. To create TFAM+VHL EpiKO mice, TFAMfl/fl mice were
crossed with VHLfl/fl mice (Jackson Laboratory, stock no. 004081), and the
progenyweremated toproduceTFAMfl/fl;VHLfl/flmice. Thesemicewere crossed
with KRT14-Cre mice and the heterozygous progeny were crossed back to the
TFAMfl/fl;VHLfl/fl line.
To obtain primary mouse keratinocytes, pups were skinned at P0.5.
Epidermis was separated from dermis by overnight incubation in dispase
(5 mg/ml) and disrupted using TrypLE Select (Invitrogen). Cells were cultured
in CnT07 media (CELLnTEC) supplemented with 100 mg/ml uridine and 1 mM
sodium pyruvate. Methyl-triphenylphosphonium, N-acetylcysteine, 2,3-dime-
thoxy-4-naphthoquinone, deferoxamine, and mustard seed oil were pur-
chased from Sigma. Mitochondria-targeted vitamin E was a kind gift of
Dr. Balaraman Kalyanaraman (Medical College of Wisconsin).
Human neonatal foreskin keratinocyte cultures were obtained from the
Northwestern University Skin Disease Research Center (NU-SDRC) and grown
in Medium 153 (Cascade) supplemented with human keratinocyte growth
supplement (Thermo Fisher). For knockdown experiments, cells were electro-
porated with 250 nmol small interfering RNA (siRNA) using a Lonza Nucleofec-
tor IIb. siRNAs were purchased from Dharmacon (stock no. D-001810-01
[non-targeting] and L-020100-00-0005 [RISP]).
Western Blots
Keratinocytes or epidermal preparations were lysed in cell lysis buffer (Cell
Signaling) or urea sample buffer, respectively. Urea sample buffer contained
8 M deionized urea, 1% SDS, 10% glycerol, 60 mM Tris (pH 6.8), 0.1% pyro-
nin-Y, and 5% b-mercaptoethanol. Lysates were resolved on 4%–20% Crite-
rion gels (Bio-Rad) and transferred to nitrocellulose. Antibodies used were
HIF-1a (Cayman), TFAM (Gift of Gerald Shadel, Yale University), a-tubulin
(Sigma), and b-actin (Sigma).
Real-Time RT-PCR
Total RNA was extracted from cells or epidermal preparations using TRIzol
reagent (Invitrogen), and 1 mg was reverse transcribed using RETROscript
first-strand synthesis kit (Ambion). Real-time PCR was performed on a Bio-
Rad CFX using iQ SYBR green Supermix (Bio-Rad). The following primers
were used: TFAM (50-CCAAAAAGACCTCGTTCAGC-30, 50-ATGTCTCCGGA
TCGTTTCAC-30), VHL (50-TCCACAGCTACCGAGGTCAT-30, 50-CGACATTGA
GGGATGGCACA 30), HIF-1a (50-GCGAGAACGAGAAGAAAAAGATGA-30,ession in the kidneys of wild-type and TFAM EpiKO mice exposed to normoxia
and TFAM EpiKO mice exposed to an epidermal application of either mustard
vels. (A–E) n = 5, (F) n = 3 mice per genotype per condition. Significance was
(legend on next page)
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50-ACTCTTTGCTTCGCCGAGAT-30), HIF-2a (50-GAACATGGCCCCCGATG
AA-30, 50-AACCCAGTCTTGGCGTTCTC-30 ), Epo (50-AATGGAGGTGGAAGAA
CAGGCCAT-30, 50-CGAAGCAGTGAAGTGAGGCTACGTA-30 ), BNIP3 (50-GAA
GCGCACAGCTACTCTCA-30, 50-TCCAATGTAGATCCCCAAGCC-30 ), CAIX
(50-GCGCTAAGCAGCTCCATACT-30, 50-GCAGGGAAGGAAGCCTCAAT-30),
CTGF (50-AGAACTGTGTACGGAGCGTG-30, 50-GTGCACCATCTTTGGCAG
TG-30), GLUT1 (50-CGGCCTGACTACTGGCTTTG-30, 50-GCCAAACACCTG
GGCAATAAG-30), PAI1 (50-GTAAACGAGAGCGGCACAGT-30, 50-GAGGAT
TGTCTCTGTCGGGT-30 ), PGK1 (50-TCTTGGGAGGCGCTAAAGTT-30, 50-AAG
GCCATTCCACCACCAAT-30), VEGF (50-GGCCTCCGAAACCATGAACT-30,
50-CTGGGACCACTTGGCATGG-30), and RPL19 (50-GAAGGTCAAAGGGAA
TGTGTTCAA-30, 50-TTTCGTGCTTCCTTGGTCTTAGA-30 ).
Epo ELISA
Mouse blood serum was collected using Serum Separator Tubes (BD). Serum
Epo levels were determined using the mouse erythropoietin Quantikine ELISA
kit (R&D Systems).
Histology and Immunostaining
Excised dorsal epidermal tissues were fixed in 10% buffered formalin and
embedded in paraffin. 4-mmsections were placed on charged slides. For auto-
mated HIF-1a immunohistochemistry, slides were prepared using the bond
polymer refine detection kit (Leica Biosystems) and staining was performed
using a Leica BOND-MAX fully automated immunohistochemistry machine.
Primary HIF-1a antibody (ab2185; Abcam) was diluted 1:200 in bond primary
antibody diluent before use. Imaging was performed using a Zeiss Axioplan 2
microscope and high-resolution AxioCam digital color camera. Image analysis
was performed with Zeiss AxioVision software.
For CD31 immunofluorescence, paraffin sections were baked overnight
at 50C and dewaxed, followed by rehydration through Sub-X and graded al-
cohols, respectively. Sections were blocked in 5% donkey serum followed by
overnight incubation in primary antibody (sc-1506; Santa Cruz Biotechnology).
A donkey anti-goat Cy3 secondary antibody (Jackson ImmunoResearch Lab-
oratories, 1:250 dilution) was then used, followed by DAPI counterstaining.
Mustard Seed Oil Treatment
Hair was removed from the backs of 9-day-old pups using Nair (Church &
Dwight). The mice were rinsed with water and dried. The backs of the mice
were then painted with either 100% EtOH or 1%mustard seed oil (allyl isothio-
cyanate, diluted in 100% EtOH). Solutions were applied every 80 min for 7 hr.
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